A Ohta Selected Research

A Ohta Research Topics

Disease

4	Neoplasms (Cancer) 06/2007 - 01/2000
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2006 - 11/2001
2	Infections 11/2022 - 11/2001
2	Osteonecrosis (Kienbock's Disease) 01/2006 - 01/2005
2	Inflammation (Inflammations) 12/2001 - 12/2001
1	Clostridium Infections 11/2022
1	Type 2 Diabetes Mellitus (MODY) 06/2014
1	Cancer Pain 03/2009
1	Pain (Aches) 03/2009
1	Behcet Syndrome (Behcet's Syndrome) 07/2004
1	Systemic Scleroderma (Systemic Sclerosis) 03/2003
1	Macular Degeneration (Age-Related Maculopathy) 03/2003
1	Hypoxia (Hypoxemia) 12/2001
1	Septic Shock (Toxic Shock Syndrome) 12/2001
1	Autoimmune Diseases (Autoimmune Disease) 11/2001
1	Glomerulonephritis 11/2001
1	Blister (Bulla) 07/2001
1	Arthritis (Polyarthritis) 06/2001
1	Experimental Arthritis 06/2001
1	Mixed Connective Tissue Disease (MCTD) 04/2001
1	Hepatitis C 04/2001
1	Congenitally Corrected Transposition of the Great Arteries 01/2001
1	Amyloidosis 09/2000
1	Contracture 09/2000
1	Vasculitis (Vasculitides) 09/2000
1	Central Nervous System Lupus Vasculitis 09/2000
1	Hepatitis 07/2000
1	Massive Hepatic Necrosis 07/2000
1	Anemia 06/2000
1	Myositis (Idiopathic Inflammatory Myopathies) 04/2000
1	Polymyositis 04/2000
1	Dehydration (Water Stress) 04/2000
1	Lymphadenopathy 04/2000
1	Sarcoidosis (Schaumann Disease) 04/2000
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 02/2000
1	Melanoma (Melanoma, Malignant) 01/2000
1	Metabolic Bone Diseases (Osteopenia) 01/2000
1	Neoplasm Metastasis (Metastasis) 01/2000
1	Bone Diseases (Bone Disease) 01/2000

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 07/2004 - 01/2000
3	Proteins (Proteins, Gene)FDA Link 06/2007 - 04/2000
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2006 - 09/2000
3	Prednisolone (Predate)FDA LinkGeneric 01/2005 - 04/2000
3	alpha-galactosylceramideIBA 07/2000 - 01/2000
2	Adenosine (Adenocard)FDA LinkGeneric 06/2007 - 12/2001
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 06/2007 - 12/2001
2	SteroidsIBA 01/2006 - 01/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2001 - 07/2000
2	LigandsIBA 01/2000 - 01/2000
2	Interleukin-12 (IL 12)IBA 01/2000 - 01/2000
1	PotassiumIBA 11/2022
1	phosphoric phenyl ester diamideIBA 11/2022
1	Disinfectants (Biocides)IBA 11/2022
1	Liraglutide FDA Link 06/2014
1	Salivary alpha-AmylasesIBA 03/2009
1	CoagulantsIBA 01/2006
1	Retinaldehyde (Retinal)IBA 03/2003
1	Protein Isoforms (Isoforms)IBA 12/2001
1	RNA IsoformsIBA 12/2001
1	Antigen Receptors (Antigen Receptor)IBA 12/2001
1	GTP-Binding Proteins (G-Protein)IBA 12/2001
1	Purinergic Receptors (Receptors, Purine)IBA 12/2001
1	Cyclic AMP (AMP, Cyclic)IBA 12/2001
1	EndotoxinsIBA 12/2001
1	Urea (Carbamide)FDA LinkGeneric 11/2001
1	Immunoglobulin G (IgG)IBA 11/2001
1	InterferonsIBA 11/2001
1	NitrogenIBA 11/2001
1	Type II Tumor Necrosis Factor ReceptorsIBA 06/2001
1	Carrier Proteins (Binding Protein)IBA 06/2001
1	Type I Tumor Necrosis Factor ReceptorsIBA 06/2001
1	Hepatitis B AntigensIBA 04/2001
1	Lipoproteins (Lipoprotein)IBA 09/2000
1	Apolipoprotein A-II (Apolipoprotein A2)IBA 09/2000
1	Anticardiolipin AntibodiesIBA 09/2000
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2000
1	IronIBA 06/2000
1	HLA-B7 Antigen (HLA B7 Antigen)IBA 04/2000
1	Platelet Membrane GlycoproteinsIBA 02/2000
1	Therapeutic UsesIBA 01/2000
1	InterleukinsIBA 01/2000
1	Interleukin-4 (Interleukin 4)IBA 01/2000
1	AntigensIBA 01/2000

Therapy/Procedure

4	Therapeutics 01/2006 - 01/2000
1	Trabeculectomy (Trabeculoplasty) 07/2001
1	Arterial Switch Operation 01/2001
1	Immunotherapy 01/2000
1	Gastrectomy 01/2000